当前位置:
X-MOL 学术
›
Nat. Rev. Endocrinol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Modelling human liver disease: from steatotic liver disease to MASH-HCC
Nature Reviews Endocrinology ( IF 31.0 ) Pub Date : 2024-10-24 , DOI: 10.1038/s41574-024-01054-z Christian Stoess, Ariel E. Feldstein
Nature Reviews Endocrinology ( IF 31.0 ) Pub Date : 2024-10-24 , DOI: 10.1038/s41574-024-01054-z Christian Stoess, Ariel E. Feldstein
Having more refined mouse models of metabolic dysfunction-associated steatotic liver disease (MASLD; also known as nonalcoholic fatty liver disease) will help to advance research into this disease. In their study, Jeong and colleagues use streptozotocin together with a high-fat diet for 6–60 weeks to investigate the progression from MASLD to hepatocellular carcinoma.
中文翻译:
人类肝病建模:从脂肪性肝病到 MASH-HCC
拥有更精细的代谢功能障碍相关脂肪性肝病 (MASLD;也称为非酒精性脂肪性肝病) 小鼠模型将有助于推进对这种疾病的研究。在他们的研究中,Jeong 及其同事将链脲佐菌素与高脂肪饮食一起使用 6-60 周,以研究从 MASLD 到肝细胞癌的进展。
更新日期:2024-10-24
中文翻译:
人类肝病建模:从脂肪性肝病到 MASH-HCC
拥有更精细的代谢功能障碍相关脂肪性肝病 (MASLD;也称为非酒精性脂肪性肝病) 小鼠模型将有助于推进对这种疾病的研究。在他们的研究中,Jeong 及其同事将链脲佐菌素与高脂肪饮食一起使用 6-60 周,以研究从 MASLD 到肝细胞癌的进展。